Claire Poll - 26 Sep 2022 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
General Counsel
Signature
/s/ Claire Poll
Issuer symbol
VRNA
Transactions as of
26 Sep 2022
Net transactions value
$0
Form type
4
Filing time
28 Sep 2022, 16:06:57 UTC
Previous filing
03 Aug 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Award $0 +800,000 +45% $0.000000 2,563,055 26 Sep 2022 Direct F1, F2, F3
holding VRNA Ordinary Shares 483,840 26 Sep 2022 By Trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents an award of Restricted Share Units ("RSUs"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 200,000 RSUs vesting on November 1, 2023 and the balance vesting in 12 equal quarterly installments thereafter.
F3 Consists of (i) 2,160,000 Ordinary Shares underlying RSUs (which may be represented by 270,000 ADSs); (ii) 403,048 Ordinary Shares underlying 50,381 ADSs; and (iii) 7 Ordinary Shares.
F4 Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.